Nuclear trafficking, histone cleavage and induction of apoptosis by the meningococcal App and MspA autotransporters by Khairalla, Ahmed S. et al.
Khairalla, Ahmed S. and Omer, Sherko A. and Mahdavi, 
Jafar and Aslam, Akhmed and Dufailu, Osman A. and 
Self, Tim and Jonsson, Ann-Beth and Geörg, Miriam and 
Sjölinder, Hong and Royer, Pierre-Joseph and Martinez-
Pomares, Luisa and Ghaemmaghami, Amir M. and 
Wooldridge, Karl G. and Oldfield, Neil J. and Ala'Aldeen, 
Dlawer A.A. (2015) Nuclear trafficking, histone cleavage 
and induction of apoptosis by the meningococcal App 
and MspA autotransporters. Cellular Microbiology, 17 
(7). pp. 1008-1020. ISSN 1462-5822 
Access from the University of Nottingham repository: 
http://eprints.nottingham.ac.uk/34390/1/Khairalla_et_al-2015-Cellular_Microbiology.pdf
Copyright and reuse: 
The Nottingham ePrints service makes this work by researchers of the University of 
Nottingham available open access under the following conditions.
This article is made available under the Creative Commons Attribution Non-commercial No 
Derivatives licence and may be reused according to the conditions of the licence.  For more 
details see: http://creativecommons.org/licenses/by-nc-nd/2.5/
A note on versions: 
The version presented here may differ from the published version or from the version of 
record. If you wish to cite this item you are advised to consult the publisher’s version. Please 
see the repository url above for details on accessing the published version and note that 
access may require a subscription.
For more information, please contact eprints@nottingham.ac.uk
Nuclear trafficking, histone cleavage and induction of
apoptosis by the meningococcal App and MspA
autotransporters
Ahmed S. Khairalla,1†§ Sherko A. Omer,1‡§
Jafar Mahdavi,1* Akhmed Aslam,1 Osman A. Dufailu,1
Tim Self,1 Ann-Beth Jonsson,2 Miriam Geörg,2
Hong Sjölinder,2 Pierre-Joseph Royer,1
Luisa Martinez-Pomares,1 Amir M. Ghaemmaghami,1
Karl G. Wooldridge,1 Neil J. Oldfield1** and
Dlawer A.A. Ala’Aldeen1
1School of Life Sciences, University of Nottingham,
Nottingham, UK.
2Department of Molecular Biosciences, Wenner-Gren
Institute, Stockholm University, Stockholm, Sweden.
Summary
Neisseria meningitidis, a major cause of bacterial
meningitis and septicaemia, secretes multiple viru-
lence factors, including the adhesion and penetra-
tion protein (App) and meningococcal serine
protease A (MspA). Both are conserved, immuno-
genic, type Va autotransporters harbouring S6-
family serine endopeptidase domains. Previous
work suggested that both could mediate adher-
ence to human cells, but their precise contribution
to meningococcal pathogenesis was unclear. Here,
we confirm that App and MspA are in vivo viru-
lence factors since human CD46-expressing trans-
genic mice infected with meningococcal mutants
lacking App, MspA or both had improved survival
rates compared with mice infected with wild type.
Confocal imaging showed that App and MspA were
internalized by human cells and trafficked to the
nucleus. Cross-linking and enzyme-linked immuno
assay (ELISA) confirmed that mannose receptor
(MR), transferrin receptor 1 (TfR1) and histones
interact with MspA and App. Dendritic cell (DC)
uptake could be blocked using mannan and
transferrin, the specific physiological ligands for
MR and TfR1, whereas in vitro clipping assays con-
firmed the ability of both proteins to proteolytically
cleave the core histone H3. Finally, we show that
App and MspA induce a dose-dependent increase
in DC death via caspase-dependent apoptosis. Our
data provide novel insights into the roles of App
and MspA in meningococcal infection.
Introduction
Autotransporters are the largest class of secreted protein
virulence factors among Gram-negative pathogens
(Henderson et al., 2004). Since the prototype auto-
transporter IgA1 protease of Neisseria gonorrhoeae was
first described (Koomey et al., 1982), over 1500 putative
autotransporters have been identified (Celik et al., 2012).
Of the three main subtypes, the most common is type
Va (or classical); these are characterized by common
structural components, including an N-terminal signal
peptide, a central functional passenger domain, and a
C-terminal translocator or β-domain (Leyton et al., 2012).
The signal peptide mediates inner-membrane transloca-
tion, whereas the β-domain is essential for translocation
of the passenger domain to the bacterial surface. Once
there, the passenger domain may be cleaved and
secreted, either auto-catalytically or via a secondary pro-
tease, cleaved but remain non-covalently bound to the
translocator domain, or remain uncleaved and displayed
at the cell surface (Henderson et al., 2004; Leyton
et al., 2012). The functions of autotransporter passenger
domains are diverse but typically relate to virulence (Benz
and Schmidt, 2011).
Neisseria meningitidis is normally a harmless com-
mensal that inhabits the human nasopharynx; it is also
capable of causing devastating invasive disease, includ-
ing meningitis and septicaemia (Stephens, 2009). The
organism elaborates numerous cell surface and secreted
virulence factors, a number of which are autotransporter
proteins, which allow them to colonize and infect the host
(Virji, 2009). Eight autotransporters have been identified
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cellular microbiology
in meningococci: IgA1 protease; MspA (meningococcal
serine protease A); App (adhesion and penetration
protein); NhhA; AutA; AutB; NadA and NalP, the majority
of which were first discovered in our laboratory (Ait-Tahar
et al., 2000; Hadi et al., 2001; Turner et al., 2002; Turner
et al., 2006). IgA1 protease, App and MspA have been
assigned, based upon their likely common ancestry
and other shared features including the nature, order and
relative positions of their catalytic residues, to the
S6-peptidase family in the MEROPS database (Rawlings
et al., 2012). This family of secreted proteins also encom-
passes homologues of IgA1 protease and App expressed
by Haemophilus influenzae (Poulsen et al., 1989; St
Geme et al., 1994), proteins belonging to the serine pro-
tease autotransporter of Enterobacteriaceae (SPATE)
group (Ruiz-Perez and Nataro, 2014) and other, as yet
uncharacterized, proteins (Rawlings et al., 2012). Typical
functions of characterized S6-peptidase family auto-
transporters relate to adherence or cleavage of
extracellular or intracellular host proteins resulting in tox-
icity and/or immune modulation (Henderson et al., 2004;
Ruiz-Perez and Nataro, 2014).
More specifically, previous work has shown that App
is expressed during meningococcal infection and car-
riage, stimulates B- and T-cells, and can induce a bac-
tericidal antibody response (Hadi et al., 2001; van Ulsen
et al., 2001). Importantly, App is an adhesin required for
optimal meningococcal adhesion to epithelial cells
(Serruto et al., 2003). After export to the cell surface,
App is (at least partially) auto-cleaved and released
from the cell surface (Hadi et al., 2001), a mechanism
suggested to assist in meningococcal detachment and
dispersal (Serruto et al., 2003). App auto-cleavage
releases a ca. 100 kDa fragment harbouring the active
peptidase domain, but in the presence of NalP (a phase-
variably expressed meningococcal surface protease),
a 140 kDa secreted App fragment, containing the
peptidase domain and an additional α-peptide region,
predominates (van Ulsen et al., 2003). The secretion of
two forms, the smaller resulting from auto-proteolysis
and the larger due to NalP processing, has also been
described for IgA1 protease and MspA (van Ulsen et al.,
2003).
MspA (also known as AusI) is a 157 kDa protein that
shows ca. 33% and ca. 36% overall amino acid identity to
App and IgA1 protease respectively (Turner et al., 2006).
Like NalP, MspA expression is phase-variable (van Ulsen
et al., 2006; Oldfield et al., 2013). Similar to App and IgA1
protease, MspA is expressed in the host and can induce
a bactericidal antibody response (Turner et al., 2006).
Escherichia coli expressing recombinant MspA were
shown to have increased adherence to some, but not all,
human cell types tested, suggesting a possible role in
adherence (Turner et al., 2006).
Here, we confirm that App and MspA are meningo-
coccal virulence factors in vivo using a human CD46
transgenic mouse model. In addition, specific roles
for the secreted fragments of App and MspA have yet
to be established. Here, we show that recombinant pro-
teins encompassing the secreted fragments of both
autotransporters are trafficked to the host cell nucleus,
proteolytically cleave histone and trigger caspase-
dependent apoptosis.
Results
In vivo confirmation that App and MspA are
meningococcal virulence factors
In order to confirm a role for App and MspA in in
vivo infection, the serogroup B meningococcal strain
MC58 and a series of mutants in which either or both
genes were deleted (MC58Δapp, MC58ΔmspA and
MC58ΔappΔmspA) were used to infect groups of 10
hCD46Ge transgenic mice. These mice have previously
been shown to express CD46 in a human-like pattern
(Mrkic et al., 1998) and develop meningococcal disease
(Johansson et al., 2003, Johansson et al., 2005, Sjölinder
and Jonsson, 2007). A further group of mice received
suspension fluid alone (negative control).
Survival rate of 100% was observed in all groups prior
to 48 h post-infection; the survival rate of the negative
control group remained at 100% at all subsequent time
points (not shown). Survival rates for the MC58-infected
group of mice were 60% and 0% at 48 and 72 h respec-
tively (Fig. 1A). Higher survival rates were apparent in
groups infected with mutant strains (Fig. 1A). For the
MC58ΔmspA group, survival rates of 80%, 20% and 20%
were observed at 48, 72 and 96 h post-infection, respec-
tively; for MC58Δapp, survival rates of 60%, 40% and
20% were observed at 48, 72 and 96 h, respectively
(P < 0.05, Fisher’s exact test, MC58 compared with
MC58Δapp-infected groups at 72 h). Highest survival
rates were observed for the group infected with
MC58ΔappΔmspA (90%, 40% and 30% at 48, 72 and
96 h, respectively) (P < 0.05, wild type compared with
MC58ΔappΔmspA at 72 h). Blood samples were also col-
lected from the tail vein for the measurement of bacterae-
mia levels. Significantly fewer bacteria were found in the
blood of animals infected with MC58ΔmspA at 6 h post-
infection and in animals infected with MC58ΔappΔmspA
at 6 and 48 h post-infection (Fig. 1B). Taken together, our
in vivo data provide confirmation that App and MspA are in
vivo meningococcal virulence factors.
App and MspA are internalized into human cells and
translocate to the nucleus
To determine whether the extracellular forms of App and
MspA interact directly with host cells, the passenger
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domain of each protein was expressed under non-
denaturing conditions as a fusion with the E. coli chaper-
one trigger factor (TF), yielding rpdApp and rpdMspA
respectively. FITC-labelled rpdApp and rpdMspA were
then co-incubated with human monocyte-derived dend-
ritic cells (DCs). Examination by confocal microscopy
clearly demonstrated that both rpdApp and rpdMspA were
internalized and at least partially localized in the nucleus
(Fig. 2). Clear pattern differences were observed between
the two proteins; App formed crescent-like accumulations
at the edge of the nucleus, whereas MspA staining was
more diffuse inside both the cytoplasm and the nucleus
(Fig. 2A and B). Recombinant TF alone, purified in the
same way as the recombinant autotransporters, did not
bind DCs (Fig. 2C and D). In separate experiments,
recombinant App and MspA passenger domains tagged
with 6 × histidine tags and purified under denaturing
conditions were also taken up by DCs, confirming
that the observed internalization was mediated by the
autotransporter passenger domains and not the TF tag
(data not shown). In addition, rpdApp and rpdMspA (but
not TF) bound were internalized and at least partially
localized to the nucleus in human brain microvascular
endothelial cells (HBMECs; Supporting Information
Fig. S1).
App and MspA enter DCs via the mannose and
transferrin receptors
Specific interaction between the autotransporters and
host cells suggested that App and MspA bind to, and
exploit, specific host molecules. To identify potential
interacting partners, we used a re-tagging approach,
in conjunction with Matrix-assisted laser desorption/
ionization time of flight (MALDI-ToF), as previously
described (Ilver et al., 1998). DCs were incubated with
recombinant proteins conjugated to the light-activated
cross-linker Sulfo-SBED. Following photoactivation and
subsequent exposure to reducing conditions to allow
transfer of the reactive biotin moiety to molecules in
close proximity to the autotransporters, the DCs were
washed, lysed, subjected to Sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) and
probed with streptavidin. Reactive bands were excised
and identified by MALDI-ToF. For both autotransporters,
two host cell surface molecules were identified: the
mannose receptor (MR; gi|55665998; mass: 169 599;
score: 1423 and 829 for rpdMspA and rpdApp, respec-
tively) and transferrin receptor 1 (TfR1; gi|4507457;
mass: 85 416; score: 1022 and 1,663 for rpdMspA and
rpdApp respectively).
Fig. 1. Infection of hCD46Ge transgenic mice with MC58 and its Δapp, ΔmspA and ΔappΔmspA mutant derivatives. Groups of 10 mice were
infected intraperitoneally with 1.2 × 109 CFU of bacteria.
A. Survival rates tended to be higher in groups infected with Δapp, ΔmspA or ΔappΔmspA (P < 0.05, Fisher’s exact test, MC58 compared with
MC58Δapp-infected groups or MC58ΔappΔmspA strain at 72 h). A negative control group (n = 7), which received re-suspension fluid alone,
showed 100% survival at all time points (not shown).
B. CFU counts were determined after plating out serial dilutions of blood. Significantly fewer bacteria were found in the blood of animals
infected with MC58ΔmspA and MC58ΔappΔmspA at 6 h post-challenge, and in animals infected with MC58ΔappΔmspA at 48 h post-infection.
Mean CFU (± SEM) from surviving animals shown. *P < 0.05; **P < 0.01; Kruskal–Wallis and Dunn’s test.
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To confirm these interactions, a series of experiments
using independent approaches were conducted. Firstly,
the specific physiological ligands for MR and TfR1
(mannan and transferrin, respectively) were used to block
internalization into DCs. Both substrates blocked the
internalization of both autotransporters, which remained
associated with the host cell surface (MspA is shown in
Fig. 2E and F). Interestingly, the observed effects of
the individual ligands were virtually identical to those of
the agents used in combination (Fig. 2G). Secondly, in
enzyme-linked immuno assay (ELISA) experiments,
rpdApp and rpdMspA were both shown to bind specifically
to TfR1; binding was highly specific when compared to
bovine serum albumin (BSA), which was used as a nega-
tive control (Fig. 3).
Mannose receptor is a multi-domain protein comprising
an N-terminal cysteine-rich (CR) domain, a fibronectin
type II domain (FNII) and eight tandemly arranged
C-type lectin-like domains (CTLD1-8) (Martinez-Pomares,
2012). To confirm binding of the two autotransporters
to MR, and to localize the MR region responsible for
binding, we utilized two human Fc-tagged recombinant
MR fragments in ELISAs. The first comprised CR-FNII-
CTLD1-3-Fc, whereas the second comprised CTLD4-
7-Fc (Martinez-Pomares et al., 2006) (Fig. 4, inset).
CTLD4-7-Fc showed strong binding to both rpdApp and
rpdMspA in a calcium-dependent manner; CR-FNII-
CTLD1-3-Fc bound neither protein, irrespective of the
presence or absence of Ca2+ (Fig. 4). Together, our data
confirm that App and MspA show calcium-specific binding
to the CTLD4-7 region of MR.
Fig. 2. Uptake of rpdMspA and rpdApp into dendritic cells (DCs). Monocyte-derived human DCs were incubated with FITC-labelled rpdMspA
(A), rpdApp (B) or TF (C). Cell nuclei were stained with Hoechst 33258. Co-localization of labelled recombinant protein and nuclei (D) was
determined using Zeiss LSM image examiner software. Mean fluorescence intensities were derived from ≥ 13 different fields from three
independent experiments. Error bars: mean of values + SD. For inhibition, DCs were pre-treated with mannan (1 mg ml−1; E), human
transferrin (1 mg ml−1; F) or both inhibitors (G) for 30 min at 37°C before being incubated with FITC-labelled rpdMspA. Cells were washed and
fixed before analysis by confocal laser scanning microscopy. All images were scanned at a resolution of 1024 × 1024 pixels using the same
laser and gains settings. The cells are representative of cells observed from three independent experiments. Scale bars = 10 μm.
Fig. 3. rpdApp and rpdMspA bind transferrin receptor 1. ELISA
plates were coated with sTfR (2 μg ml−1) or 1% BSA. Following
overnight incubation, wells were washed and rpdApp or rpdMspA
(5 μg ml−1) added. Wells were probed with guinea pig anti-rpdApp
or rpdMspA, respectively, followed by anti-guinea pig IgG alkaline
phosphatase conjugate. Each test was performed in triplicate wells
and on a least three independent occasions. Values represent the
mean + SEM from three experiments.
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App and MspA interaction with histones
In addition to MR and TfR1, our cross-linking experiments
also identified several histone proteins as potential
rpdApp and rpdMspA-interacting molecules [for rpdApp,
Histone H2B (score 557), H4 (score 489) and H2A
(score 623) and for rpdMspA, histone H2B (score 1625),
H3.1 (score 1759) and H4 (score 378)]. Histones are
major structural components of chromatin and play
a role in chromatin condensation and gene regulation
(Khorasanizadeh, 2004). Five major histone families have
been described: H1/H5; H2A; H2B; H3; and H4. We
examined the binding of rpdApp and rpdMspA to a panel
of representative recombinant human histones (Fig. 5A).
Both bound to each of the histones tested, with rpdApp
showing greater binding to all histones compared with
rpdMspA. Both proteins bound the core histones (H2A,
H2B, H3.1 and H4) at higher levels than to the linker
histone (H1) (Fig. 5A).
Core histones are heavily post-translationally modified
in order to provide functional variation (Rothbart and
Strahl, 2014). One major modification of histone H3 is
proteolytic cleavage of the N-terminal tail region (Duncan
Fig. 4. Calcium-specific binding of rpdApp and rpdMspA to
mannose receptor. ELISA plates were coated with rpdApp,
rpdMspA (5 μg ml−1) or 1% BSA. Following incubation, wells were
washed and MR fragments CR-FNII-CTLD1-3-Fc or CTLD4-7-Fc
dissolved in lectin buffer supplemented with or without 10 mM Ca2+
were added. Bound MR was detected with a mouse anti-human
immunoglobulin Fc-specific antibody coupled to alkaline
phosphatase. Each test was performed in triplicate wells and
on a least three independent occasions. Values represent the
mean + SD from three experiments. The domain structure of MR is
indicated in the schematic (inset). CR = cysteine-rich domain (red);
FNII = fibronectin type II domain (blue); CTLDs = C-type lectin-like
domains (green).
Fig. 5. rpdApp or rpdMspA interaction with
histones.
A. ELISA plates were coated with
recombinant human histones (5 μg ml−1).
Following washing, rpdApp and rpdMspA
(5 μg ml−1) were added; bound
autotransporters were detected using rabbit
anti-TF, followed by anti-rabbit IgG alkaline
phosphatase conjugate. Specific binding was
calculated by subtracting the BSA (negative
control) values from the histone-
autotransporter absorbance. Tests were
performed in triplicate wells and on two
independent occasions. Values represent
the mean + SD from two experiments.
B. Dose-dependent cleavage of recombinant
histone H3.1 by rpdMspA and rpdApp.
Histones were incubated with rpdMspA or
rpdApp at 37°C for 15 h. Cathepsin L (CathL;
6 μg ml−1) and TF (20 μg ml−1) were used as
positive and negative controls for cleavage,
respectively. Reactions were stopped by the
addition of SDS-PAGE sample buffer and
cleavage products subjected to SDS-PAGE.
Proteins were strained with Simply Blue Safe
stain (Invitrogen). The percentage of clipped
H3.1 shown for each lane was determined by
densitometry using ImageJ software for data
acquisition.
C. Cleavage of histone H3.1 by rpdMspA and
rpdApp could be inhibited by 1 mM PMSF,
confirming that the serine endopeptidase
activity of rpdApp and rpdMspA was
responsible for cleavage.
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et al., 2008; Santos-Rosa et al., 2009). Given that MspA
and App harbour serine endopeptidase domains, we
examined the ability of rpdApp and rpdMspA to
proteolytically cleave H3. Our data showed that rpdApp
and rpdMspA could cleave H3 in a dose-dependent
manner, with the latter exhibiting higher protease activity
(Fig. 5B). Inhibition of autotransporter-mediated clipping
of H3 using the serine protease inhibitor phenylme-
thanesulfonyl fluoride (PMSF) confirmed that cleavage
was due to the serine endopeptidase activity of rpdApp
and rpdMspA (Fig. 5C).
App and MspA induce cell death by
caspase-dependent apoptosis
Histone post-translational modifications are involved
in numerous processes, including gene expression,
DNA replication and repair, and apoptosis (Zhang and
Pradhan, 2014). To further understand the effect of expos-
ing DCs to rpdApp and rpdMspA, we investigated the
ability of both proteins to induce cell death. After expo-
sure, DCs were collected, stained with propidium iodide
(PI), and the proportion of PI-stained (dead) and
unstained (live) cells was determined by flow cytometry.
Our data showed that rpdApp and rpdMspA (but impor-
tantly not TF alone) could induce a dose-dependent
increase in cell death (Fig. 6). As expected, treatment with
staurosporine or nocodazole (known apoptosis-inducing
agents) also led to a significant increase in DC cell death.
Importantly, addition of heat-inactivated or proteinase
K-treated rpdApp and rpdMspA did not result in a signifi-
cant increase in DC cell death, eliminating the possibility
that trace amounts of contaminating LPS might account
for the effect (Fig. 6). Further experiments showed that
Z-VAD-FMK (a pan-caspase inhibitor) (Van Noorden,
2001) could significantly inhibit the rpdApp- and rpdMspA-
mediated effects, confirming that these proteins induce
cell death by a caspase-dependent pathway (Fig. 7).
Discussion
Previously, we identified and partially characterized App
and MspA: two meningococcal proteins that share a
number of common features; both are immunogenic, type
Va autotransporters, which mediate bacterial–host cell
adhesion (Hadi et al., 2001; Serruto et al., 2003; Turner
et al., 2006). Additionally, their functional passenger
domains, harbouring serine protease motifs, are released
from the cell surface via auto-cleavage or by the action of
NalP (van Ulsen et al., 2003). Here, we provide further
evidence of commonalities between App and MspA,
while additional molecule-specific functions cannot be
excluded, especially since App and MspA only exhibit ca.
34% overall amino acid identity.
The significance of App and MspA in disease was con-
firmed using a human CD46-expressing murine infection
model. Mutation of app or mspA did not dramatically sup-
press disease; unsurprising given that meningococcal
pathogenesis is a multifaceted process involving complex
meningococcal–host interactions (Virji, 2009). While the
relatively small group size of 10 mice per group (for
reasons of cost and availability) may have precluded
Fig. 6. rpdApp and rpdMspA induce a dose-dependent increase in
human dendritic cell death. 1 × 105 human monocyte-derived
dendritic cells were stimulated with TF, rpdApp or rpdMspA at 20
or 60 μg ml−1. To eliminate the effect of contaminating LPS in
the protein preparations, 60 μg ml−1 heat-inactivated (60B) or
proteinase K-treated (60PK) proteins were used as negative
controls. Staurosporine (St; 2 μM) and nocodazole (Noco;
60 μg ml−1) were used as positive controls for cell death
respectively. After exposure, cells were collected and stained with
propidium iodide (PI) followed by flow cytometric analysis, and
PI-positive cells (dead) were compared with unstained cells (live)
for the determination of cell death. Statistically significant
differences, compared with medium alone, were assessed by
one-way ANOVA and Student’s t-test: *P < 0.05; **P < 0.01;
***P < 0.001. Values shown are the mean + SD from five
independent donors.
Fig. 7. Inhibition of rpdApp- and rpdMspA-mediated cell death
using Z-VAD-FMK. Human monocyte-derived dendritic cells were
stimulated with TF, rpdApp or rpdMspA at 60 μg ml−1 in the
presence or absence of 10 μM Z-VAD-FMK. After exposure, the
cells were collected and stained with propidium iodide (PI) followed
by flow cytometric analysis, and PI-positive cells (dead) were
compared with unstained cells (live) for the determination of cell
death. Statistically significant differences, between cell death in the
presence or absence of inhibition, were assessed by one-way
ANOVA and Student’s t-test: ***P < 0.001. Values shown are the
mean + SD from three independent donors.
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some differences in survival rates between groups
being statistically significant; nevertheless, statistically
significant differences were observed in virulence and in
vivo growth/survival at some time points. Highest sur-
vival rates were observed for the mutant lacking both
autotransporters, suggestive of (at least partial) functional
redundancy between the two proteins. Previous work sug-
gesting a role for both proteins in adhesion (Hadi et al.,
2001; Serruto et al., 2003; Turner et al., 2006), and sub-
sequent experiments in this study showing that both pro-
teins traffic towards the host cell nucleus, clip histone H3
and induce apoptosis, support this hypothesis. Redun-
dancy is a recurring feature of meningococcal pathogen-
esis, enabling maintenance of key phenotypes (e.g.
adhesion or iron acquisition), while also allowing for
evasion of host defences via the modulation of surface
epitopes (Hill and Virji, 2012). App is constitutively
expressed across all meningococcal serogroups (Hadi
et al., 2001). In contrast, not all strains harbour mspA,
some strains contain a mspA gene with a single
nucleotide mutation, which places a premature stop
codon in frame, and MspA expression is phase-variable
due to the presence of a poly-cytosine tract within the
coding sequence that is presumed to be susceptible to
slipped-strand mispairing during replication (van Ulsen
et al., 2006; Oldfield et al., 2013).
Our data show that both autotransporters specifically
bind to both MR and TfR1. These receptors mediate
endocytosis via separate mechanisms and recognize dif-
ferent types of substrates. TfR1 is a transmembrane
homo-dimeric glycoprotein, expressed by virtually all
cells, which is required for internalization of iron-loaded
transferrin via endosomes through clathrin-dependent
receptor-mediated endocytosis (Hayes et al., 1997;
Aisen, 2004; Syed et al., 2006). It is also involved in the
cellular entry of several viruses, including hepatitis C virus
(Martin and Uprichard, 2013), New World haemorrhagic
fever arenaviruses (Demogines et al., 2013), mouse
mammary tumour virus (Wang et al., 2008), and canine
and feline parvoviruses (Parker et al., 2001). To our
knowledge, this is the first study showing TfR1 involve-
ment in the uptake of a bacterial ligand.
Mannose receptor is a member of the C-type (calcium-
dependent) lectin receptor superfamily, which is involved
in innate immune responses as well as mediating selec-
tive endocytosis (Sallusto et al., 1995; Linehan et al.,
1999). MR is expressed mainly by DCs and macrophages
and contains an N-terminal CR domain, an FNII, and
a CTLD1-8 (Martinez-Pomares, 2012). Through these
various domains, MR can bind a variety of endogenous
and exogenous ligands, with the CTLD domains (impli-
cated here in App and MspA binding) commonly binding
allergens and microbial products (Taylor et al., 1992).
MR has been implicated in the cellular uptake of several
bacteria, including Enterococcus faecalis, Listeria
monocytogenes, E. coli, Bacillus subtilis and Streptococ-
cus pneumoniae (Zamze et al., 2002; Macedo-Ramos
et al., 2011; Hashino et al., 2012; Tsuruta et al., 2013).
Clearly, MR and TfR1 have little in common; nevertheless,
both their substrates (when used alone) blocked the inter-
nalization, but not the binding, of rpdApp and rpdMspA
into DCs, perhaps implying that autotransporter internali-
zation requires the cooperation of both receptors. Inter-
estingly, we observed that maximal nuclear localization of
rpdApp and rpdMspA occurred later in HBMECs than DCs
(8 h and 45 min, respectively). We hypothesize that this
results from differential receptor expression, but this
requires experimental confirmation. Additionally, further
work is required to define the regions of both receptors
and their autotransporter ligands, which are involved in
uptake.
There is an emerging recognition that secretion of
proteins that target the host cell nucleus, subsequently
altering host cell biology, is an important pathogenic
mechanism of Gram-negative bacteria (Bhavsar et al.,
2007). Examples of such secreted proteins include
cytolethal distending toxins (McSweeney and Dreyfus,
2004; Matangkasombut et al., 2010), Anaplasma phago-
cytophilum AnkA (Park et al., 2004), Salmonella enterica
SspH1 (Haraga and Miller, 2003) and Yersinia YopM
(Benabdillah et al., 2004); our data suggest that App and
MspA are also members of this group. Once in the
eukaryotic cytoplasm, proteins < 40 kDa can access the
nucleus by passive diffusion; larger proteins are com-
monly transported by nuclear transporter receptors follow-
ing recognition of nuclear localization signals (NLSs) in
the cargo protein (Gerace, 1992; Lange et al., 2007;
Marfori et al., 2011). NLSs are short motifs rich in basic
amino acids, such as arginine and lysine (Marfori et al.,
2011). Importantly, some secreted fragments of Neisserial
IgA1 protease contain NLS motifs; these have been
shown to promote the accumulation of reporter proteins
in the eukaryotic cell nucleus (Pohlner et al., 1995). App
also contains at least one putative NLS (933RRRSRRSR940
in MC58 App) (Hadi et al., 2001), whereas NLS
sequences are not evident in MspA (Turner et al., 2006).
Whether the putative NLSs in App are functional, and
precisely how App and MspA are trafficked to the nucleus
will require additional experimentation. Intriguingly, the
NLSs present in both IgA1 protease and App are present
in their respective α-peptide regions. These are present in
the larger secreted fragments of IgA1 protease and App
(160 and 140 kDa, respectively), but absent from the
smaller, auto-proteolytically released, forms (110 and
100 kDa respectively) (van Ulsen et al., 2003). The bio-
logical significance of releasing the different forms of
these autotransporters is currently unknown, but frag-
ments containing or lacking the α-peptide may differ in
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their ability to access the nucleus and may therefore
elicit different cellular responses. The recombinant
proteins used in this study correspond closely to the
larger, α-peptide-containing, fragments secreted by
N. meningitidis. These were used because the low abun-
dance of both App and MspA in culture supernatants has
impeded the purification of experimentally useful amounts
of autotransporter fragments direct from the complex
meningococcal secretome and consequently hampered
the definition of the sites of auto-proteolytic and NalP-
mediated cleavage.
Eukaryotic chromosomal DNA is packaged into
nucleosomes; these contain two copies each of the core
histones H2A, H2B, H3 and H4 (Luger et al., 1997).
Histone modifications, including methylation, acetylation
and phosphorylation, play important roles in numerous
cellular processes, including DNA replication and gene
expression (Strahl and Allis, 2000; Khorasanizadeh,
2004). Histone H3 is the target of many modifications; one
is the proteolytic cleavage of the N-terminal tail region. For
example, cathepsin L cleavage of the H3 N-terminus is
associated with gene activity during mouse cell develop-
ment (Duncan et al., 2008), and in Saccharomyces
cerevisiae, H3 clipping has been associated with gene
activation during stationary phase (Santos-Rosa et al.,
2009). Our data show that rpdApp and rpdMspA can bind
core histone proteins and can proteolytically cleave H3 in
a dose-dependent manner. Our results also suggest that
rpdMspA binds histones less efficiently than rpdApp, yet
cleaves H3 more efficiently. The generation of rpdApp and
rpdMspA derivatives harbouring substitutions at their
respective catalytic serine residues will allow a more
accurate determination of their relative histone-binding
efficiencies in the absence of cleavage. Interestingly,
based on their mobility on SDS-PAGE gels, the clipped H3
fragments generated by both autotransporters appeared
similar to those generated by cathepsin L, suggesting
cleavage at, or near, the same region (A21-K27) (Duncan
et al., 2008), but this requires additional experimental
confirmation.
Since histone H3 tail clipping can regulate gene expres-
sion and histone modifications can influence additional
cellular processes including apoptosis (Füllgrabe et al.,
2010), we examined the effect of App and MspA on DCs.
This showed that both proteins induce cell death by a
caspase-dependent pathway. In the study by Robinson
et al., meningococcal secreted proteins (MSPs) induced
complex changes in the gene expression profile of human
meningothelial cells, leading to an increased resistance to
apoptosis (Robinson et al., 2004). Thus, effects mediated
by specific proteins (i.e. App and MspA) have to be con-
sidered in the context of a complex multifaceted interac-
tion involving numerous other ligand–receptor and cell
signalling events.
In summary, our data provide novel and important
insights into the roles of App and MspA in meningococcal
infection and notably provide further evidence of
commonalities between them, namely they both (i) bind
mannose receptor and transferrin receptor, (ii) translocate
to the nucleus, (iii) bind and proteolytically leave histone,
and (iv) induce cell death.
Experimental procedures
Bacterial strains and culture conditions
Escherichia coli strain JM109 was used for plasmid propagation,
and either XL10-Gold or BL21-Gold (DE3) was used for recom-
binant protein expression (Table 1). Strains were grown at 37°C
in lysogeny broth (LB) or on LB agar supplemented, where
appropriate, with ampicillin (100 μg ml−1), streptomycin and
spectinomycin (100 μg ml−1) or kanamycin (25 μg ml−1). N.
meningitidis strains were grown at 37°C, in an atmosphere of air
plus 5% CO2, on Columbia agar with chocolated horse blood
(Oxoid) or in brain–heart infusion (BHI) broth (Oxoid) supple-
mented, where appropriate, with streptomycin and spectinomycin
(100 μg ml−1) and/or kanamycin (50 μg ml−1) (Table 1).
Construction of app, mspA and app/mspA
double mutants
We previously described a streptomycin/spectinomycin-resistant
app mutant of strain MC58 (Hadi et al., 2001). To construct
an mspA mutant with a different selectable marker, the
streptomycin/spectinomycin cassette was removed from
pTOPOMspAflΔΩ (Turner et al., 2006) (Table 1) by KpnI diges-
tion and replaced with a 1.5 kb kanamycin resistance cassette
extracted from pJMK30 after digestion with KpnI. The resulting
plasmid, pTOPOMspAflΔKan, was confirmed by DNA sequenc-
ing and subsequently used to transform MC58 and MC58Δapp by
natural transformation and allelic exchange to yield strains
MC58ΔmspA and MC58ΔappΔmspA respectively (Table 1).
Murine infection experiments
These utilized an hCD46Ge transgenic mouse line (CD46+/+)
(Mrkic et al., 1998). Animals were age- (6–8 weeks) and sex-
matched and verified for the CD46+/+ genotype by polymerase
chain reaction (PCR). Meningococcal strains were grown for 18 h
at 37°C, in an atmosphere of air plus 5% CO2, on Gonococcus
(GC) agar base (Difco) with Kellogg’s supplement. Bacteria were
resuspended in GC broth, and each mouse challenged
intraperitoneally with 1.2 × 109 colony-forming units (CFU) in
100 μl of GC broth. Bacterial inoculums were verified by retro-
spective viable counts. Ten mice were inoculated per group,
except for the negative control group (n = 7), which were sham-
challenged with 100 μl of GC broth. All investigations were
carried out blind. The health status of all mice was closely moni-
tored for 96 h. At the indicated time points, whole blood samples
were collected from the tail vein. Bacteraemia levels were deter-
mined by serial dilution of blood samples, plating aliquots
onto agar and subsequently determining numbers of CFU. All
mouse experiments were performed at the animal facility of the
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Wenner-Gren Institute, Stockholm University. Animal care and
experiments were conducted according to the institution’s guide-
lines for animal husbandry and all protocols were approved by
the Swedish Ethical Committee on Animal Experiments (Approval
ID: N380/08).
Construction of plasmids encoding recombinant proteins
Primers app-QE70-For_nos/app-QE70-Rev_noB and mspa-
QE70-For_nos/mspa-QE70-Rev_noB (Table 2) were used to
amplify fragments of ca. 3.4 kb encoding amino acids 43G to
1179N and 27S to 1152A, from N. meningitidis MC58 app and mspA
respectively. PCR products were cloned into pGEM-T Easy,
used according to the manufacturer’s instructions, to obtain
pGEMTEpdapp and pGEMTEpdmspA respectively (Table 1).
The cloned inserts were subsequently removed by digestion with
BglII and SphI and ligated into pQE70, digested with the same
enzymes, to yield plasmids pQE70pdapp and pQE70pdmspA
respectively.
pCold TF-App, encoding App 43G to 1179N with N-terminal TF
and 6 × histidine tags, was constructed by GenScript Corporation
utilizing the cold shock expression vector pCold TF. pCold
TF-MspA encoding MspA 27S to 1152A with N-terminal TF and
6 × histidine tags was constructed by amplifying the relevant
mspA fragment from MC58 using primers pColdTF-MspA(F)
and pColdTF-MspA(R) (Table 2). After digestion with KpnI and
HindIII, the PCR product was ligated to KpnI- and HindIII-
digested pCold TF to yield pCold TF-MspA.
Protein expression and purification
rpdApp and rpdMspA were expressed in E. coli XL10-Gold har-
bouring plasmids pQE70pdapp or pQE70pdmspA, respectively,
purified under denaturing conditions and re-natured by dialysis.
Briefly, cultures were grown to an OD600 of 0.6 and induced with
1 mM IPTG for 3 h. Cells were harvested by centrifugation at
3,000 × g for 10 min, resuspended in 5 ml of denaturing wash
buffer (200 mM Tris–HCl, pH 7.5, 100 mM EDTA, 10% Triton
X-100) per gram (wet weight) of cells. About 1 mg ml−1 lysozyme
(Sigma) was added and the suspension was incubated at room
temperature for 30–60 min. Cell suspensions were subjected to
sonication (10 cycles of 10 s on, 20 s off) using an MSE Soniprep
150, frozen at −80°C, thawed and subjected to repeat sonication.
The samples were then centrifuged at 5000 × g for 30 s, and the
supernatant was collected and centrifuged at 10 000 × g for
30 min at 4°C. Pellets were re-suspended in denaturing wash
buffer, incubated at room temperature for 15 min and centrifuged
at 10 000 × g for 30 min at 4°C. Pellets were solubilized in
1 × SDS-PAGE sample buffer [0.125 M Tris–HCl (pH 6.8), 1%
Table 1. Characteristics of bacterial strains and plasmids used in this study.
Strain or plasmid Description Source or reference
E. coli
JM109 Plasmid propagation strain Promega
XL10-Gold Expression strain for pQE70-based plasmids Stratagene
BL21-Gold (DE3) Expression strain for pCold TF-based plasmids Stratagene
N. meningitidis
MC58 Wild-type serogroup B strain ATCC
MC58Δapp app replaced with Ω cassette Hadi et al. (2001)
MC58ΔmspA mspA replaced with kanamycin cassette This study
MC58ΔappΔmspA mspA mutant derivative of MC58Δapp This study
Plasmids
pTOPOMspAflΔΩ mspA mutagenesis plasmid containing Ω cassette Turner et al. (2006)
pJMK30 Source of kanamycin resistance cassette van Vliet et al. (1998)
pTOPOMspAflΔKan mspA mutagenesis plasmid containing kanamycin cassette This study
pGEM-T Easy PCR cloning vector Promega
pGEMTEpdapp Region of MC58 app encoding 43G–1179N in pGEM-T Easy This study
pGEMTEpdmspA Region of MC58 mspA encoding 27S–1152A in pGEM-T Easy This study
pQE70 Expression vector Qiagen
pQE70pdapp Expression vector encoding 6 × histidine-tagged 43G–1179N fragment of MC58 App This study
pQE70pdmspA Expression vector encoding 6 × histidine-tagged 27S–1152A fragment of MC58 MspA This study
pCold TF Protein expression vector Takara Bio
pCold TF-App Expression vector encoding 6 × histidine-tagged 43G–1179N of MC58 App fused to trigger factor GenScript
pCold TF-MspA Expression vector encoding 6 × histidine-tagged 27S–1152A of MC58 MspA fused to trigger factor This study
Table 2. Primers used in this study.
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SDS, 5% glycerol, 0.0004% bromophenol blue] and proteins
separated by SDS-PAGE (7.5% gels; Protean–II, Bio-Rad).
Gels were stained briefly with Simply Blue Safe stain
(Invitrogen) and the recombinant protein excised, transferred to
Midi D-Tube dialysers [molecular weight cut-off (MWCO)
6–8 kDa, Novagen) and electro-eluted according to the recom-
mendations of the manufacturer. Proteins were then dialysed in
a fresh D-Tube against phosphate-buffered saline (PBS) for
48 h and concentrated using Microcon centrifugal filter units
(30 kDa MWCO).
For expression and purification of recombinant proteins under
non-denaturing conditions, E. coli BL21-Gold (DE3) cells har-
bouring pCold TF-App, pCold TF-MspA or pCold TF were grown
at 37°C with shaking to an OD600 of 0.6, after which the culture
was cooled to 15°C for 30 min without shaking. IPTG was added
to 0.5 mM and the culture incubated with shaking at 15°C for
24 h. Following incubation, cells were harvested by centrifugation
at 5000 × g at 4°C for 10 min. The cell pellet was resuspended in
50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0. Cells
were lysed by intermittent sonication for 5 min in an ice-water
bath, and the bacterial lysate was centrifuged at 11 000 × g at
4°C for 30 min. The supernatant was removed, filtered through a
0.22 μm sterile syringe filter (Sartorius) and recombinant protein
purified using HisPur cobalt resin (Thermo Scientific) using a
gravity flow column (Sigma). Briefly, the supernatant–resin
mixture was washed with 10 column volumes of 50 mM
NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0. After
washing, recombinant protein was eluted in 50 mM NaH2PO4,
300 mM NaCl, 250 mM imidazole, pH 8.0, concentrated using
30 kDa MWCO centrifugal concentrators (Millipore) and dialysed
against sterile PBS.
Generation of antisera and immunoblotting
Dunkin-Hartley female guinea pigs were immunized subcutane-
ously four times at 3 week intervals with 50 μg of natively purified
rpdApp or rpdMspA emulsified in Freud’s complete (first immu-
nization only) or incomplete adjuvant. Guinea pig anti-App or
anti-MspA antisera were used in immunoblotting experiments
1:4000 diluted in blocking buffer (1% BSA in PBS/0.05% Tween
20) and incubated for 2 h. After washing three times in PBS-T,
membranes were incubated for 2 h with anti-guinea pig immu-
noglobulin G (IgG)-alkaline phosphatase conjugate (CovalAb)
(1:4,000 diluted in blocking buffer). After washing with PBS-T, the
blots were developed using BCIP/NBT-Blue liquid substrate
(Sigma). Alternatively, detection of 6 × histidine-tagged recombi-
nant proteins was performed using mouse anti-penta histidine
monoclonal antibody (Qiagen; 1:10,000 diluted), followed
by anti-mouse IgG alkaline phosphatase conjugate (Sigma;
1:30 000 diluted).
Generation of DCs and cell culture
Heparinized venous blood was obtained from healthy human
volunteers and peripheral blood mononuclear cells (PBMCs) iso-
lated by density gradient centrifugation over Ficoll-Histopaque
(Sigma). Isolated PBMCs were washed three times in Hank’s
balanced salt solution (Gibco) and resuspended in RPMI 1640
medium (Gibco). Purified PBMCs were then incubated at 4°C
for 30 min with mouse anti-human CD14-coated micro beads
(Miltenyi Biotec), washed with RPMI 1640 and separated mag-
netically using a magnetic activated cell sorting (MACS) separa-
tor (Miltenyi Biotec). CD14 negative cells were washed off the
column and retained (CD14-positive) cells eluted after removal of
the column from the magnetic separator. Eluted CD14-positive
cells (monocytes) were washed twice with RPMI 1640 and
seeded into 6-well flat-bottomed culture plates at approximately
1 × 106 cells per well in RPMI 1640 medium supplemented with
10% fetal bovine serum (FBS), 100 U ml−1 penicillin, 100 μg ml−1
streptomycin and 2 mM L-glutamine. To stimulate the differentia-
tion of monocytes into DCs, 50 ng ml−1 granulocyte-macrophage
colony-stimulating factor (GM-CSF; Perotech) and 250 IU ml−1
IL-4 (R&D Systems) were added to the media. DCs were har-
vested after incubation for 6 days at 37°C in an atmosphere of
5% CO2.
Human brain microvascular endothelial cells (HBMECs;
ATCC) were cultured on human fibronectin-coated flasks (BD
Biosciences) in endothelial cell medium (ECM; ScienCell-USA)
supplemented with 5% FBS, endothelial cell growth supplement
(ECGS; ScienCell-USA), 100 U ml−1 penicillin and 100 μg ml−1
streptomycin. Cells were maintained at 37°C in an atmosphere of
5% CO2.
Cell internalization assays
Proteins were FITC (DCs) or Cy5 (HBMECs) labelled using the
Lightning-Link conjugation kit (Innova Biosciences) according to
the manufacturer’s instructions. DC uptake assays were carried
out in RPMI 1640 media supplemented with 10% FBS, at 37°C in
an atmosphere of air plus 5% CO2. DCs (1 × 106 cells) were
plated on poly-L-lysine-coated 35 mm glass base dishes (Iwaki)
and incubated for 1 h. DCs were then incubated with labelled
rpdApp, rpdMspA or TF (30 μg ml−1) for 45 min. Following incu-
bation, cell nuclei were stained with 10 μg ml−1 Hoechst 33258
(Sigma) in PBS for 10 min at room temperature and rinsed thrice
with PBS. The cells were fixed in 1% paraformaldehyde in PBS
for 10 min and then washed thrice before analysis by confocal
microscopy. Imaging was performed using a Zeiss LSM 710
confocal laser scanning microscope, equipped with lasers at 488
and 364 nm for excitation of FITC and Hoechst 33258 respec-
tively. For blocking experiments, DCs were incubated for 30 min
with human transferrin (Sigma; 1 mg ml−1) or S. cerevisiae
mannan (Sigma; 1 mg ml−1) for 30 min at 37°C prior to the addi-
tion of labelled proteins.
For HMBECs, confluent monolayers were harvested and
seeded onto fibronectin-coated coverslips in 24-well plates at a
seeding density of 5 × 105 cells per well and incubated for 16 h.
Cells were then treated with labelled rpdApp, rpdMspA or TF
(30 μg ml−1) for 8 h. After treatment, cells were washed thrice and
fixed in 1% paraformaldehyde for 10 min at room temperature
and rinsed thrice with PBS. Cells were mounted using proLong
Gold anti-fade with DAPI (Life Technologies) to stain cell nuclei.
Confocal imaging was performed using a Zeiss LSM 710
equipped with lasers at 633 and 405 nm for excitation of Cy5 and
DAPI respectively. All images were scanned at a resolution of
1024 × 1024 pixels using the same laser and gains settings. The
images collected in the two channels were later merged and
analysed using Zeiss LSM software. Co-localization for DCs was
determined using Zeiss LSM image examiner software using the
threshold method; a value of 25% for both FITC and Hoechst
(Blue, nucleus staining) channels was applied. For HMBECs,
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co-localization was determined using Velocity 6.3.1 software
(PerkinElmer).
Re-tagging
Dendritic cells were incubated for 2 h with rpdApp or rpdMspA to
which the Sulfo-SBED cross-linker (Pierce) had been conjugated
according to the manufacturer’s recommendations (5 μg of
cross-linker tagged protein to 106 cells). After incubation,
cells were harvested by centrifugation at 250 × g for 5 min,
resuspended in PBS-T and exposed to UV light (365 nm) for
5 min. Cells were washed, resuspended in 10 mM dithiothreitol
(DTT) (Sigma) as a reducing agent and incubated for 10 min.
Following three washes in PBS, cells were boiled and proteins
resolved by SDS-PAGE. Biotin-tagged proteins were identified by
probing with streptavidin. Reactive proteins bands were excised,
digested with sequencing-grade trypsin (Promega) and analysed
using a Micromass Tof-Spec E (Micromass).
ELISA
Soluble human transferrin receptor (sTfR1; BioVendor) was
diluted in PBS to 2 μg ml−1 and 100 μl aliquots added to 96-well
microtiter plates (PolySorp, amino surface immobilizer; Nunc).
PBS + 1% BSA was used as a negative control. Plates were
incubated overnight at 4°C, washed in PBS-T, and blocked in
PBS + 1% BSA for 1 h. 100 μl of aliquots of recombinant protein
(5 μg ml−1 in PBS) were added and incubated overnight at 4°C.
Plates were washed and incubated with guinea pig anti-App or
anti-MspA (1:4,000 diluted) overnight at 4°C. After washing,
plates were incubated with alkaline phosphatase-conjugated
anti-guinea pig IgG (CovalAb; diluted 1:4000) for 1 h. Following
washing, bound antibody was detected using p-nitrophenyl phos-
phate substrate (pNPP; Sigma) diluted in buffer (100 mM Tris–
HCl, 100 mM NaCl, 1 mM MgCl2, pH 9.5) to a final concentration
of 1 mg ml−1. The absorbance at 405 nm was measured using a
BioTek EL800 plate reader.
To detect binding of MR fragments to rpdApp or rpdMspA,
CR-FNII-CTLD1-3-Fc and CTLD4-7-Fc were purified as previ-
ously reported (Martinez-Pomares et al., 2006), and ELISAs
undertaken as above, with modifications. Wells were coated with
rpdApp or rpdMspA (5 μg ml−1) or 1% BSA for 5 h at 4°C. Plates
were washed with 10 mM Tris–HCl (pH 7.5), 10 mM Ca2+,
154 mM NaCl and 0.05% Tween 20 (lectin buffer). Following
blocking, wells were incubated with MR fragments (2 μg ml−1) for
2 h. Wells were subsequently washed and probed with alkaline
phosphatase-conjugated anti-human IgG (Fc-specific) antibody
(Sigma) diluted 1:5,000. When assays were performed to
examine binding in the presence or absence of Ca2+, lectin buffer
and calcium-free lectin buffer were used respectively.
Non-post-translationally modified, non-tagged, recombinant
human histones (New England Biolabs) were used to assess
binding with rpdApp and rpdMspA. Briefly, wells were coated
overnight with histones (5 μg ml−1) or PBS + 1% BSA. Following
PBS-T washes, wells were blocked with PBS + 1% BSA for 1 h,
then recombinant protein (5 μg ml−1) was added for 5 h at 4°C.
Wells were washed and rabbit anti-TF antibody (GenScript)
(1:1000 diluted) was added. Following overnight incubation, wells
were washed and anti-rabbit IgG alkaline phosphatase conjugate
(Sigma; 1:30 000 in 1% BSA) was added for 1 h before bound
antibody is detected using pNPP substrate.
Histone clipping
Recombinant histone H3.1 (New England Biolabs; 200 μg ml−1
final concentration) and natively purified recombinant protein (0.6–
20 μg ml−1 final concentration) were mixed in a total volume of
40 μl of PBS and incubated at 37°C for 15 h. Mouse cathepsin L
(MP Biomedical; 6 μg ml−1 final concentration) was used as a
positive control for cleavage. Reactions were stopped by the
addition of 5 × sample buffer [0.62 M Tris–HCl (pH 6.8), 5% SDS,
25% glycerol, 12.5% β-mercaptoethanol, 0.25 M DTT, 0.002%
bromophenol blue], followed by immediate boiling for 5 min.
Aliquots of cleavage products were subjected to SDS-PAGE, and
gels were strained with Simply Blue Safe stain (Invitrogen).
Densitometry was performed on a 16 bit greyscale TIFF file
of the scanned gel image using ImageJ software for data acquisi-
tion. PMSF (1 mM; Sigma) was added to assays for inhibition
experiments.
Apoptosis assays
About 1 × 105 DCs were stimulated with recombinant proteins (20
or 60 μg ml−1) for 24 h in RPMI 1640 media. To eliminate the effect
of contaminating LPS in the protein preparations, heat-inactivated
(100°C for 15 min) or proteinase K-treated (100 μg ml−1 Sigma
56°C for 60 min) proteins were used as negative controls. Expo-
sure for 4 h to staurosporine (2 μM; Sigma) and nocodazole
(60 μg ml−1; Sigma) was used as a positive control for cell death.
Inhibition experiments were performed as above using 60 μg ml−1
recombinant proteins and in the presence or absence of 10 μM
Z-VAD-FMK (Z-Val-Ala-Asp-fluoromethylketone; Sigma). After
exposure, cells were washed and resuspended in PBS containing
1 μg ml−1 PI (Sigma), followed by flow cytometric analysis using a
BD FACSAria flow cytometer. Data were analysed using the
FACSDiva and WinMDI flow cytometry software, and PI-positive
cells (dead) were compared with unstained cells (live) for the
determination of cell death.
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Supporting information
Additional Supporting Information may be found in the online
version of this article at the publisher’s web-site:
Fig. S1. Uptake of rpdMspA and rpdApp into human brain
microvascular endothelial cells (HBMECs). HBMECs were incu-
bated with Cy5-labelled rpdMspA (A), rpdApp (B) or TF (C). Cell
nuclei were stained with DAPI. Co-localisation of labelled recom-
binant protein and nuclei (D) was determined using Velocity 6.3.1
software (Perkin Elmer). Mean fluorescence intensities were
derived from ≥ 3 different fields. Error bars: mean of values + SD.
All images were scanned at a resolution of 1024 × 1024 pixels,
using the same laser and gains settings. The cells are repre-
sentative of cells observed from multiple experiments. Scale
bars = 10 μm.
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